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Abstract
 
Numerous bacterial products such as lipopolysaccharide potently induce type I interferons
(IFNs); however, the contribution of this innate response to host defense against bacterial in-
fection remains unclear. Although mice deficient in either IFN regulatory factor (IRF)3 or the
type I IFN receptor (IFNAR)1 are highly susceptible to viral infection, we show that these
mice exhibit a profound resistance to infection caused by the Gram-positive intracellular bacte-
rium 
 
Listeria monocytogenes
 
 compared with wild-type controls. Furthermore, this enhanced bac-
terial clearance is accompanied by a block in 
 
L. monocytogenes
 
–induced splenic apoptosis in
IRF3- and IFNAR1-deficient mice. Thus, our results highlight the disparate roles of type I
IFNs during bacterial versus viral infections and stress the importance of proper IFN modula-
tion in host defense.
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Introduction
 
Type I IFNs (IFN-
 
 
 
/
 
 
 
) were the first cytokines to be dis-
covered, being named for their potent effects on viral “inter-
ference” (1). These cytokines play a critical role in the innate
antiviral response by inhibiting cellular proliferation, pro-
moting apoptosis, activating the microbicidal function of
macrophages and NK cells, and by linking innate and adap-
tive immune responses (2–4). Induction of type I IFN gene
expression in response to viral infection is accomplished by a
sophisticated interplay of transcription factors of the IFN
regulatory factor (IRF) family (5). Upon detection of viral
entry into the cytoplasm, IRF3 becomes phosphorylated and
translocates to the nucleus to drive transcription of the
 
IFN-
 
 
 
 gene. Binding of IFN-
 
  
 
to the type I IFN receptor
(IFNAR), composed of subunits IFNAR1 and IFNAR2,
results in the phosphorylation of the transcription factor
STAT1
 
 
 
/
 
 
 
, leading to induction of IFN target genes (2).
Studies have also found that bacterial products, such as LPS,
can induce IRF3-dependent type I IFN gene expression
through interaction with Toll-like receptors (6–9). Although
the molecular mechanisms by which bacterial products in-
duce type I IFNs have been studied extensively (10), little is
known of the functional significance of type I IFN induc-
tion during a bacterial infection.
 
Listeria monocytogenes 
 
is a Gram-positive intracellular bac-
terium that causes sepsis and meningitis in immunocom-
promised individuals and severe fetal infections in pregnant
women (11–13). Furthermore, 
 
L. monocytogenes
 
 has been
used widely as a laboratory model for intracellular bacterial
infections (12). Recent studies have indicated that 
 
L. mono-
cytogenes
 
 can induce high levels of IFN-
 
  
 
once inside the
cytoplasm of infected macrophage cells (14–17). To better
understand the functional consequences of type I IFN sig-
naling during a bacterial infection, we have analyzed mice
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deficient in various components of the type I IFN system
in the context of an 
 
L. monocytogenes
 
 infection.
 
Materials and Methods
 
Mice.
 
6–12-wk-old C57BL/6 (The Jackson Laboratory)
mice were used as wild-type controls in all experiments, unless
noted. 
 
MyD88
 
 
 
/
 
  
 
mouse lines were provided by S. Akira (Osaka
University, Osaka, Japan). To obtain 
 
IFNAR1
 
 
 
/
 
 
 
, 
 
IFNAR1
 
 
 
/
 
 
 
,
and matched littermate wild-type controls on a C57BL/6 genetic
background, A129 mice (B&K Universal Limited) were back-
crossed with C57BL/6 (The Jackson Laboratory) mice for five
generations. All mice, including F9 C57BL/6 
 
IRF3
 
 
 
/
 
  
 
mice,
were maintained and bred under specific pathogen-free condi-
tions in the UCLA-DLAM mouse facility and experiments were
conducted within the parameters of our approved protocol.
 
Bacteria. L. monocytogenes
 
 strain 10403S was used for the in
vitro portions of this study and all in vivo 
 
L. monocytogenes
 
 infec-
tion experiments were performed using 
 
L. monocytogenes
 
 express-
ing an immunodominant H-2D
 
b
 
–restricted epitope from the
lymphocytic choriomeningitis virus–NP protein. The epitope
was embedded in an 
 
hly
 
 fusion protein that was integrated into
the 
 
L. monocytogenes
 
 chromosome using a genetic system pro-
vided by P. Lauer and R. Calendar (University of California,
Berkeley, Berkeley, CA). Although we found this particular
strain of 
 
L. monocytogenes
 
 to be approximately five times less viru-
lent than wild-type 
 
L. monocytogenes
 
 as determined by LD
 
50
 
,
IRF3
 
 
 
/
 
  
 
mice were also more resistant to infection by wild-type
 
L. monocytogenes
 
 compared with control mice (unpublished data).
 
L. monocytogenes
 
 was grown in brain heart infusion (BHI) broth
with 200 
 
 
 
g/ml streptomycin. Bacteria were grown to midloga-
rithmic phase, pelleted, washed three times using PBS, and stored
as glycerol stocks at 
 
 
 
80
 
 
 
C in small aliquots until use. The con-
centration of 
 
L. monocytogenes
 
 was quantified by plating serial di-
lutions on BHI agar plates and counting colonies after growth at
37
 
 
 
C for 24–36 h.
 
Cell Culture.
 
Murine bone marrow–derived macrophages
(BMMs) were differentiated from adherent bone marrow cells
from mice as described previously (18). In brief, bone marrow
cells were isolated and maintained in macrophage differentiating
media (1
 
  
 
DMEM [Mediatech Inc.], 10% fetal bovine serum,
100 U/ml penicillin, 100 
 
 
 
g/ml streptomycin, and 30% L929
conditioned medium) for 7 d. Purity was assayed to be 94–99%
CD11b
 
  
 
and negative for several contaminating markers.
 
Immunoblotting.
 
Cell fractionation and nuclear and cytoplas-
mic immunoblotting were performed as described previously (6).
Anti-IRF3 was obtained from Zymed Laboratories. Anti–
upstream stimulating factor (USF)-2 and anti-STAT1 were ob-
tained from Santa Cruz Biotechnology, Inc. Antibodies specific
to the phosphorylated forms of STAT1 were obtained from Cell
Signaling Technologies. Cell lysates were quantified and 40 
 
 
 
g of
nuclear extract or 25 
 
 
 
g of cytoplasmic extract was loaded in
each lane of an acrylamide gel and separated by SDS-PAGE. Gels
were transferred to Immobilon-P membranes (Millipore) and im-
munoblotted according to the antibody manufacturer’s recom-
mended instructions.
 
ELISA.
 
To assay cytokine levels, serum was isolated from in-
fected and uninfected mice as indicated. IFN-
 
  
 
and IL-6 levels
were assessed using the mouse IFN-
 
  
 
(AN-18) and IL-6 ELISA
sets from BD Biosciences according to the manufacturer’s protocol.
 
Quantitative Real-Time PCR (Q-PCR).
 
RNA was isolated
using TRIzol Reagent (Invitrogen) according to the manufac-
turer’s protocol. RNA was quantitated and 2 
 
 
 
g RNA was used
to make cDNA templates using Superscript II (Invitrogen) ac-
cording to the manufacturer’s instructions and oligo-dT primers.
Q-PCR analyses were performed using the iCycler thermocycler
(Bio-Rad Laboratories). Q-PCR was conducted in a final vol-
ume of 20 
 
 
 
l containing the following: Taq polymerase, 1
 
  
 
Taq
buffer (Stratagene), 125 
 
 
 
M dNTP, SYBR™ Green I (Molecu-
lar Probes), and Fluorescein (Bio-Rad Laboratories), using oligo-
dT cDNA as the PCR template. Amplification conditions were
as follows: 95
 
 
 
C for 3 min, 40 cycles of 95
 
 
 
C for 20 s, 55
 
 
 
C for
30 s, and 72
 
 
 
C for 20 s. Primers were used to amplify a specific
100–120-bp fragment corresponding to these respective genes.
Primer sequences for 
 
L32
 
,
 
 IFN-
 
 
 
,
 
 Mx1
 
,
 
 IL-6
 
, and 
 
IP10
 
 are the
same as those published previously (6, 7). Primers for 
 
TRAIL
 
,
 
TGTP
 
,
 
 PML
 
,
 
 Daxx
 
,
 
 PKR
 
, and 
 
IRF1
 
 are as follows: 
 
TRAIL
 
: for-
ward, ACCTCAGCTTCAGTCAGCACTTC, reverse, TGTA-
AGTCACAGCCACAGACACAG; 
 
TGTP
 
: forward, CGATT-
TCCCCATTTGTTTGC, reverse, TGGCCCACCAGTAAC-
TGAAGA; 
 
PML
 
: forward, CAGGCTCTTAGCACCCAC-
ATG, reverse, AGGCATCCCTTACTTTCAGCTTT; 
 
Daxx
 
:
forward, TTCGGGAAAAT CGAACCTTG, reverse, CCTCA-
GTCTTGTCTTGCATCATTG; 
 
PKR
 
: forward, GGAGCAC-
GAAGTACAAGCGC, reverse, GCACCGGGTTTTGTAT-
CGA; and 
 
IRF1
 
: forward, TCCAAGTCCAGCCGAGACA, re-
verse, TGCTGAGTCCATCAGAGAAAGTGT. 
 
L32
 
 expression
measurements were conducted in tandem with the gene of inter-
est. All data is presented as relative expression units after normal-
ization to the average 
 
L32
 
 value to control for loading of total
RNA. Measurements were conducted in triplicate.
 
Infections.
 
For in vitro infections, bacteria were diluted from
glycerol stocks into media (1
 
  
 
DMEM, 7% fetal bovine serum,
no antibiotics), added onto cells, and incubated at 37
 
 
 
C, 10%
CO
 
2
 
, until harvest. Concentration of bacteria in the infectious
stimulus was verified by plating serial dilutions on the appropriate
agar plates. For in vivo infections, 
 
L. monocytogenes
 
 was grown to
midlogarithmic phase, pelleted, washed, resuspended in PBS three
times, and quantified by visible spectrometry readings at 600 nm.
For intravenous injection, bacteria were diluted in pyrogen-free
saline and 200 
 
 
 
l was injected into the lateral tail vein. Concentra-
tion of bacteria in the infectious dose was controlled by plating se-
rial dilutions on BHI/streptomycin agar plates. For determination
of bacterial recovery, mice were killed and the livers and spleens
were homogenized in 1% Triton-X solution. Serial dilutions of
homogenates were plated on BHI/streptomycin agar plates and
colonies were counted after growth at 37
 
 
 
C for 24–36 h.
 
Histology.
 
Wild-type, 
 
IRF3
 
 
 
/
 
 
 
, and 
 
IFNAR
 
 
 
/
 
  
 
mice were
inoculated with 5 
 
  
 
10
 
5 
 
CFUs of 
 
L. monocytogenes
 
 intravenously.
Livers were harvested 3 d later, fixed in formalin, and embedded in
paraffin. Sections were cut at 4 
 
 
 
m and mounted onto poly-l-
lysine–coated slides (Fisher Scientific). Serial sections were then
processed for hematoxylin and eosin staining according to standard
protocols.
TdT-mediated dUTP Nick-End Labeling (TUNEL) Assays.
Spleens were removed from infected mice and snap-frozen in
OCT (Sakura Finetek). 4- m sections were cut and mounted
onto poly-l-lysine–coated slides. Splenic tissue was fixed using
4% paraformaldehyde, permeabilized using 0.1% Triton and 0.1%
sodium citrate, and then double stranded DNA breaks were la-
beled using an in situ Cell Death Kit (Roche) according to the
manufacturer’s protocol. Sections were then counterstained using
DAPI and analyzed using a Leica DM IRBE fluorescent micro-
scope at a magnification of 10. Openlab software (Improvision)
was used for image acquisition.O’Connell et al. 439
Results
Induction of IFN-   by L. monocytogenes Requires IRF3.
The transcription factor IRF3 has been shown to mediate the
induction of the IFN-  gene in response to both viruses and
Toll-like receptor signaling (6, 19). To determine if induc-
tion of type I IFNs by L. monocytogenes also involves IRF3,
primary murine BMMs were challenged with L. monocyto-
genes and IRF3 activation was assayed by nuclear transloca-
tion. As shown in Fig. 1 A, L. monocytogenes can induce
strong IRF3 nuclear translocation by 4 h after infection. We
also found that L. monocytogenes induced nuclear translocation
of the NF- B subunit p65 by 1 h, whereas USF-2 was mon-
itored as a loading control (Fig. 1 A). Next, we sought to as-
sess whether IRF3 is required for the induction of the type I
IFN system. L. monocytogenes induction of IFN-  occurred
normally in BMMs deficient in the Toll-like receptor and
IL-1R adaptor molecule MyD88, which has been shown to
play an important protective role during an L. monocytogenes
infection in vivo (Fig. 1 B; references 20 and 21). However,
IRF3 /  BMMs infected with L. monocytogenes were unable
to induce expression of IFN- . As a control, we found that
IFN-  production in BMMs deficient in the IFNAR sub-
unit IFNAR1 was similar to wild-type.
Once produced, type I IFNs can signal in an autocrine
and paracrine manner leading to the phosphorylation-
dependent activation of STAT1 through IFNAR (2). Con-
sistent with our observations that IRF3 is required for L.
monocytogenes–induced IFN-   production, STAT1 phos-
phorylation also required IRF3 (Fig. 1 C). In contrast, L.
monocytogenes–challenged MyD88 /  BMMs, which were
capable of IFN-  production after L. monocytogenes infec-
tion, induced STAT1 phosphorylation similar to wild-type
controls (Fig. 1 C). STAT1 phosphorylation was dependent
upon type I IFNs, as BMMs deficient in IFNAR1 did not
activate STAT1 (Fig. 1 C). Collectively, these findings indi-
cate that like some viruses, L. monocytogenes induction of
IFN-  and subsequent STAT1 activation also occur through
an IRF3-dependent, MyD88-independent pathway.
Mice Deficient in IRF3 Have an Enhanced Ability to Clear
Infection by L. monocytogenes. IRF3 plays a protective role
during viral infection (19). To assess the functional role of
IRF3 activation during a bacterial infection, we inoculated
both wild-type and IRF3-deficient mice with a strain of L.
monocytogenes expressing an epitope from the NP protein
(see Materials and Methods). Surprisingly, we found that
56% of IRF3-deficient mice survived a dose of L. monocyto-
genes that was lethal for all mice in the wild-type control
group (Fig. 2 A). Although bacterial titers were roughly
equivalent on day 1 (not depicted), IRF3-deficient mice had
 100-fold fewer bacteria compared with wild-type controls
in both the spleen and liver by day 3 after a sublethal L.
monocytogenes infection (Fig. 2 B). A similar pattern was
noted when using a dose of L. monocytogenes that was ap-
Figure 1. Induction of IFN-  by L. monocytogenes re-
quires IRF3. (A) BMMs from C57BL/6 wild-type mice
were infected with L. monocytogenes at a multiplicity of in-
fection of 1 and IRF3 and p65 nuclear translocation were
assayed at the indicated times by immunoblotting using nu-
clear extract. USF-2 was also assayed as a loading control.
(B)  MyD88 / ,  IRF3 / ,  IFNAR1 / , and wild-type
BMMs were infected with L. monocytogenes as described
above and assayed at the indicated time points for IFN- 
gene expression by Q-PCR and (C) phospho-STAT1 / ,
or total STAT1 /  by immunoblotting. Results shown are
representative of at least two independent experiments, and
Q-PCR results are expressed in relative expression units
and have been normalized to L32 mRNA levels.Type I Interferons Enhance Listeria monocytogenes Infection 440
proximately one tenth the LD50 (not depicted). Histological
analysis showed that the L. monocytogenes–infected wild-type
livers displayed more severe tissue pathology relative to
IRF3 /  livers at 3 d after infection (Fig. 2 C). Livers from
wild-type mice demonstrated extensive perivascular infiltrate
and multiple intravascular thrombi, whereas IRF3 /  livers
were relatively clear. Collectively, these data demonstrate
that IRF3 activation inhibits the host’s ability to control L.
monocytogenes growth during the early stages of infection.
Type I IFNs Sensitize Mice to L. monocytogenes Infection.
It has been clearly shown that mice lacking the IFNAR are
extremely susceptible to many viruses (22); however, initial
studies using mice on a 129SV/EV genetic background did
not find a significant difference in survival between L.
monocytogenes–infected wild-type and IFNAR1 /   mice
(23). To determine if the L. monocytogenes–resistant pheno-
type observed in the IRF3 /   mice, which are on a
C57BL/6 background, was due to the absence of type I
IFN signaling or by means of a type I IFN–independent
pathway, we used IFNAR1 /  mice that were crossed onto
the C57BL/6 genetic background for five generations.
These mice, along with their littermate wild-type and het-
erozygous controls, were challenged with L. monocytogenes.
Only 7% of IFNAR1 /  and 33% of IFNAR1 /  mice re-
mained viable, whereas  77% of IFNAR1 /  mice sur-
vived the infection (Fig. 3 A). These data strongly indicate
that IRF3-mediated induction of type I IFNs results in en-
hanced severity of L. monocytogenes infection. Furthermore,
functional analysis of type I IFNs during L. monocytogenes
infection in various genetic backgrounds may improve our
understanding of both antibacterial and antiviral immune
responses in heterogenous human populations.
To further challenge the hypothesis that type I IFNs in-
terfere with the host’s ability to control an L. monocytogenes
infection, we chose to investigate whether elevated type I
IFN levels could enhance susceptibility to an L. monocyto-
genes infection. We and others have found that intravenous
injection of poly I:C results in strong induction of type I
IFNs, including both IFN-  and IFN- 4 (24 and unpub-
lished data). Therefore, wild-type mice were inoculated
with a combination of poly I:C and L. monocytogenes, or ei-
ther agent alone. Mice given a sublethal dose of L. monocy-
togenes remained healthy and viable (Fig. 3 B). Likewise,
the administration of poly I:C alone did not appear to in-
fluence the health status of the mice by day 9 (Fig. 3 B).
However, when mice were given the combination of a
sublethal dose of L. monocytogenes along with poly I:C, all
of the mice died by day 4 (Fig. 3 B).
To test whether the increased L. monocytogenes resistance
observed in the IFNAR1 /  versus wild-type mice was due
to improved L. monocytogenes clearance, we infected both
wild-type and IFNAR1 /  mice with a sublethal dose of L.
monocytogenes. After 3 d of infection, both the liver and
spleen of the IFNAR1 /  mice had a substantially lower L.
monocytogenes titer compared with wild-type controls (Fig.
3 C). Furthermore, wild-type livers suffered from signifi-
cant  L. monocytogenes–induced tissue pathology, whereas
IFNAR1 /  livers appeared relatively clear from insult (Fig.
3 D). To determine if the decreased survival observed in
mice receiving poly I:C in addition to L. monocytogenes was
mediated by type I IFNs, we gave both wild-type and
IFNAR1 /  mice the same poly I:C   L. monocytogenes
treatment and monitored L. monocytogenes clearance from
the spleen and liver by day 3. As shown in Fig. 3 C, wild-
type mice receiving L. monocytogenes plus poly I:C exhib-
ited drastically higher bacterial titers in both the liver and
spleen compared with wild-type mice receiving L. monocy-
togenes alone. When these same studies were performed in
IFNAR1 /  mice, poly I:C had almost no effect on the
levels of bacteria in the liver or spleen (Fig. 3 C). Histolog-
ical analysis of wild-type livers from poly I:C and L. mono-
cytogenes coadministered mice revealed multiple parenchy-
mal abscesses compared with the less severe lesions found
in the those mice injected with L. monocytogenes alone (Fig.
3 D). Consistent with the CFU analysis, livers from
IFNAR1 /  mice with or without coadministration of poly
I:C were relatively clear of tissue abscesses (Fig. 3 D).
These findings indicate that the adverse effects elicited by
Figure 2. Mice deficient in IRF3 have an enhanced ability to clear in-
fection by L. monocytogenes. (A) IRF3 /  (n   8) and wild-type control
mice (n   8) were infected intravenously with 1.5   106 L. monocytogenes
and viability was assayed daily for 9 d. (B) IRF3 /  (n   4) and wild-type
mice (n   4) were infected intravenously with 5   105 L. monocytogenes
for 3 d, at which time the L. monocytogenes titer in the spleen and liver was
assayed and presented as CFUs. (C) A portion of the IRF3 /  and wild-
type livers from B were fixed, sectioned, and subjected to a histological
analysis after hematoxylin and eosin staining. All data are representative of
at least two independent experiments.O’Connell et al. 441
poly I:C during the L. monocytogenes infection are largely
mediated by type I IFNs, and confirm the ability of type I
IFNs to potently enhance L. monocytogenes pathogenicity.
Type I, But Not Type II, IFN Signaling Is Impaired in L.
monocytogenes–infected IFNAR1 /  Mice. To examine the
biological basis by which type I IFNs increase sensitivity to
L. monocytogenes infection, we examined potential targets for
type I IFNs that are known to play important roles in L.
monocytogenes clearance. Both type I and II IFNs are critical
in combating certain viral infections through the up-regula-
tion of overlapping and nonoverlapping gene subsets (25).
However, only type II IFN, or IFN- , has been shown to
contribute to antibacterial immunity, as mice deficient in
the IFN-   receptor quickly succumb to infection by L.
monocytogenes (26). Furthermore, mice deficient in various
proteins required for IFN-  signaling, including IRF2 and
IRF8, have been shown to be highly susceptible to infec-
tion by L. monocytogenes (27). To determine if the absence of
type I IFN signaling can modulate the inducible levels of
IFN- , we measured IFN-  serum levels in mice that had
been infected with L. monocytogenes. We found that IFN- 
serum levels in IFNAR1 /  and wild-type mice were in-
duced to similar levels 24 h after L. monocytogenes infection
(Fig. 4 A). IFN target genes such as IP10, TGTP, and IRF1
were also induced to similar levels in both wild-type and
IFNAR1 /  mice, suggesting that these genes are targets of
IFN-  signaling during L. monocytogenes infection (Fig. 4 B).
The inflammatory cytokine IL-6 was also induced to similar
levels in IFNAR1 /  and wild-type mice (Fig. 4 A). In con-
trast, induction of Mx1, PKR, TRAIL, and Daxx was com-
pletely ablated in the IFNAR1 /  spleen, indicating that this
set of genes is specifically activated by type I IFNs (Fig. 4 B).
These findings argue that the resistance to L. monocytogenes
infection observed in IRF3- and IFNAR1-deficient mice
compared with wild-type controls was not a result of altered
IFN-  production and subsequent signaling, or altered pro-
duction of the proinflammatory cytokine IL-6.
L. monocytogenes–infected Macrophages Up-regulate a Type I
IFN–dependent Apoptotic Gene Subset. Fig. 4 B demon-
strates that among the type I IFN–specific genes up-regu-
lated in the spleen during infection are genes with known
roles in promoting apoptosis such as TRAIL, PKR, and
Daxx (Fig. 4 B and reference 28). Macrophage cells have
been shown to undergo type I IFN–dependent apoptosis in
response to L. monocytogenes (16). Because macrophages make
up a fraction of the splenocyte population, we wanted to
Figure 3. Type I IFNs sensitize mice to L. monocyto-
genes infection. (A) IFNAR1 /  (n   13), IFNAR1 / 
(n   8), and IFNAR1 /  (n   14) mice were infected
intravenously with 1.5   106 L. monocytogenes and via-
bility was assayed daily for 9 d. (B) Wild-type mice were
challenged with 5   105 L. monocytogenes (n   6), 200
 g poly I:C (n   6), or the combination of the two
(n    6), and viability was assayed daily for 9 d. (C)
IFNAR1 /  and wild-type control mice were infected
intravenously with 5   105 L. monocytogenes either in the
absence or presence of 200  g poly I:C. After 3 d, the
mice were killed and the L. monocytogenes titer was de-
termined in the liver (n   4) and spleen (n   4), and
presented as CFUs. (D) A portion of the livers from C
were fixed, sectioned, and subjected to a histological
analysis after hematoxylin and eosin staining. All data are
representative of at least two independent experiments.Type I Interferons Enhance Listeria monocytogenes Infection 442
determine whether they might be contributing to the
type I IFN–dependent expression of apoptotic genes
during the L. monocytogenes infection. Wild-type and
IFNAR /  BMMs were challenged with L. monocytogenes
for up to 8 h. Gene expression was analyzed at the indi-
cated time points by Q-PCR (Fig. 4 C). We found that
macrophage cells, similar to the heterogenous splenocyte
population, respond to L. monocytogenes by up-regulating
numerous proapoptotic genes, such as PKR, Daxx, TRAIL,
and PML, in a type I IFN–dependent manner. As a con-
trol, type I IFN was not required for the up-regulation of
the proinflammatory cytokine IL-1  (Fig. 4 C). These data
indicate that L. monocytogenes induction of type I IFN–
dependent proapoptotic genes observed in the spleen likely
involves splenic macrophages.
L. monocytogenes–induced Splenic Apoptosis Is Dependent on
Type I IFNs. One of the hallmark effects mediated by type
I IFNs is the induction of apoptosis in infected cells, which
has been shown to drastically inhibit the viral life cycle (28).
To assess whether L. monocytogenes can also induce apoptosis,
mice were infected with L. monocytogenes and splenocyte
apoptosis was assessed 48 h later by TUNEL assay. We ob-
served massive apoptosis, as indicated by TUNEL  cells, in
the splenic tissue from infected mice compared with unin-
fected controls (Fig. 5 A). TUNEL  cells were widely dis-
tributed and highly prevalent throughout the spleens in a fol-
licular pattern. To determine whether the type I IFN
pathway contributes to splenic apoptosis after infection by L.
monocytogenes, wild-type, IFNAR1 / , and IRF3 /  mice
were infected with L. monocytogenes and TUNEL assays were
performed 48 h later. Despite roughly equivalent bacterial
loads at this time point (Fig. 5 B), L. monocytogenes–infected
IFNAR1 /  and IRF3 /  spleens exhibited a drastic reduc-
tion in splenic apoptosis compared with wild-type controls
(Fig. 5 A). These results demonstrate that L. monocytogenes–
induced apoptosis in vivo is largely dependent on type I IFN
production and signaling.
Discussion
Although type I IFN up-regulation plays an important role
in fighting viral infection (23), our results demonstrate that
Figure 4. Type I, but not Type II, IFN signaling is in-
hibited in L. monocytogenes–infected IFNAR1    mice. (A)
The spleens and serum from IFNAR1 /  and wild-type
mice infected with 1.5   106 L. monocytogenes were re-
moved 24 h after infection and serum IFN-  and IL-6 lev-
els were assayed by ELISA. (B) The splenocyte mRNA
was subjected to a Q-PCR analysis to assay IP10, IRF1,
TGTP, IL-6, Mx1, TRAIL, PKR, and Daxx expression.
(C) IFNAR1 /  and wild-type BMMs were infected with
L. monocytogenes at a multiplicity of infection of 1 and as-
sayed at the indicated time points for IL-1 , Mx1, PKR,
Daxx, TRAIL, and PML gene expression by Q-PCR. Re-
sults shown are representative of at least two independent
experiments. Q-PCR data are presented in relative expres-
sion units and have been normalized to L32 mRNA levels.O’Connell et al. 443
these cytokines actually inhibit host defense against L. monocy-
togenes infection. Compared with wild-type mice, IRF3- and
IFNAR1-deficient animals have a greatly improved ability to
control the bacterial challenge. Furthermore, exogenous de-
livery of the type I IFN–inducing agent poly I:C dramatically
sensitized mice to L. monocytogenes inoculation in an
IFNAR1-dependent manner. These studies indicate that L.
monocytogenes benefits from the cellular programming medi-
ated by type I IFNs. Although the complete mechanism by
which type I IFNs inhibit host immunity to L. monocytogenes
is likely complex due to the pleiotropic cellular effects medi-
ated by these cytokines (2), our findings suggest that IRF3-
and IFNAR1-deficient mice might be more resistant to L.
monocytogenes infection because their splenocytes do not suc-
cumb to type I IFN–mediated apoptosis.
We observed massive apoptosis in lymphocyte-rich folli-
cles in the spleens of L. monocytogenes–infected wild-type
mice by 2 d after infection. Previous reports have found
similar patterns of apoptosis clearly involving uninfected T
and B lymphocytes, and potentially other cell types, within
close proximity to L. monocytogenes–laden macrophages
(29). These findings suggest that one or more autocrine/
paracrine factors produced by the infected macrophages in-
duce apoptosis in neighboring cells and possibly macro-
phages themselves. However, blocking such known media-
tors of apoptosis as TNF, IL-1, IFN- , and nitric oxide had
no effect on the apoptotic lesion (29). In our study, we
found greatly reduced numbers of TUNEL  cells in the
spleens of mice deficient in either IRF3 or IFNAR1 com-
pared with wild-type spleens despite the presence of similar
bacterial loads by 2 d after infection. Thus, type I IFNs are
likely the paracrine factors responsible for the splenic apop-
tosis observed in L. monocytogenes–infected mice.
Although splenic T and B lymphocytes are clearly being
killed by L. monocytogenes, Jiang et al. (30) have suggested
that nonspecific, but not antigen-specific, T cells are tar-
geted for deletion in this situation. However, experiments
using SCID mice have indicated that B and T cells do not
Figure 5. L. monocytogenes–induced splenic apoptosis is
dependent on type I IFNs. (A) Spleens from IFNAR1 / ,
IRF3 / , and wild-type mice that had been infected with
1.5   106 L. monocytogenes 48 h previously were removed
and subjected to a TUNEL assay followed by DAPI stain-
ing of the nuclei. Pictures were taken using a 10  lens. (B)
Portions of the spleens from wild-type (n   3), IRF3 / 
(n   3), and IFNAR1 /  (n   4) mice used for TUNEL
assays in A were assayed and presented as CFUs 2 d after
infection with 1.5   106 L. monocytogenes. All data repre-
sent three independent experiments.Type I Interferons Enhance Listeria monocytogenes Infection 444
contribute to the early response against L. monocytogenes
(12). Thus, it is highly plausible that other important cell
types are also being targeted by L. monocytogenes–induced
type I IFNs, resulting in apoptosis. Macrophage cells have
been shown to undergo type I IFN–dependent apoptosis
when incubated with L. monocytogenes in vitro (16). Consis-
tent with these observations, we found type I IFN–depen-
dent up-regulation of a subset of proapoptotic genes in L.
monocytogenes–infected macrophage cells, similar to the ex-
pression profile observed in the L. monocytogenes–infected
spleen. Furthermore, there were approximately twice
as many macrophages and neutrophils in IRF3- and
IFNAR1-deficient spleens 2 d after L. monocytogenes inocu-
lation (unpublished data). Previous reports have shown that
depletion of macrophages or neutrophils results in en-
hanced L. monocytogenes infection during the early stages of
the infection (12). Hence, the reduction of these cell types
in wild-type mice relative to IRF3- and IFNAR1-deficient
animals may explain why wild-type mice exhibit decreased
immunity against L. monocytogenes.
Both type I and II IFNs play important roles in combating
viral infections through the up-regulation of overlapping and
nonoverlapping gene subsets (25). In response to bacterial
infections, only type II IFN has been shown to play a pro-
tective role through the induction of a Th1 cell immune re-
sponse (25). As type II IFN production and subsequent sig-
naling are not disrupted in IFNAR1 /  mice (Fig. 4), this
particular cytokine appears to be sufficient for induction of
IFN target genes necessary to mount an effective response to
L. monocytogenes. Conversely, type I IFN–specific target
genes such as Mx1, PKR, Daxx, and TRAIL have been
shown to inhibit viral replication and regulate cellular apop-
tosis (25). Thus, although type I IFN target genes play an
imperative role in antiviral defense, they might be detrimen-
tal when mounting an immune response to L. monocytogenes.
This study raises an open question as to why phagocytic
cells would respond to a pathogen by secreting factors that
potently inhibit host immunity. One attractive possibility is
that L. monocytogenes has evolved the ability to activate type
I IFNs to overcome host defenses. The L. monocytogenes
protein listeriolysin O (LLO) has recently been shown to
be required for L. monocytogenes induction of IFN-   in
macrophage cells (15). Furthermore, L. monocytogenes defi-
cient in LLO exhibit a drastic reduction in both virulence
and splenic apoptosis compared with wild-type L. monocy-
togenes in vivo (29), whereas the LLO protein is alone suffi-
cient to induce apoptosis in lymph nodes (31). Further
studies are needed to determine if the LLO protein, or
some other L. monocytogenes–produced ligand, is sufficient
to induce expression of type I IFNs.
Type I IFNs may also play a different biological role in
other genetic backgrounds or during later stages of the in-
fection. For example, type I IFNs might contribute to the
adaptive response to L. monocytogenes by regulating the ex-
pression of MHC and costimulatory molecules required for
developing antigen-specific CTLs, as it has been shown to
do during viral infections (4). However, Auerbuch et al.
(32) have not found a significant defect in immunological
memory during a secondary challenge in L. monocytogenes–
immunized IFNAR /   mice compared with wild-type
controls. Further investigation is also required to character-
ize whether type I IFNs play harmful or protective roles
against other bacteria or nonviral pathogens in general. A
recent study has found that the administration of type I
IFNs results in increased loads of Mycobacterium tuberculosis
in the lungs (33), lending further evidence that other infec-
tious pathogens may also benefit from these cytokines.
Consequently, patients suffering from viral infections might
be more susceptible to certain bacteria due to the effects of
virally induced type I IFNs. Thus, our results highlight the
importance of proper regulation of the IFN pathway in re-
sponse to specific pathogens due to the disparate roles these
cytokines play during bacterial versus viral infection.
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